Improving Healthcare for Women Globally
Women deserve better. Earlier answers. More certainty. Less waiting.
CureMetrix was founded in 2014 on the belief that AI can close the gap between what medicine is capable of and what patients actually receive. We build imaging tools for radiologists — precision AI that integrates into existing workflows and helps clinicians detect what matters, sooner. From breast cancer to heart disease, the consequences of a late diagnosis falls hardest on women. We exist to change that. Not because it's a good business — though we believe deeply that doing good and doing well go hand in hand — but because the technology is here, the need is urgent, and waiting is not an option.
Press & News
Stay up to date with the latest announcements, product launches, and milestones from CureMetrix.
FDA Clears CureMetrix's cmAngio 2.0, Introducing BAC Quantification and Age-Based Context
CureMetrix received FDA 510(k) clearance for cmAngio 2.0, an AI software that detects and quantifies breast arterial calcification on screening mammograms. The updated version adds quantitative measurement, age-based context, and prevalence information to help physicians provide patients with more meaningful health information.
Read moreJuly 20, 2026Breast Center of New England Expands Personalized Breast Imaging Services with CureMetrix's cmAngio®
Breast Center of New England, a women-owned practice in New Hampshire, has adopted cmAngio®, an FDA-cleared AI tool for detecting breast arterial calcification from routine mammograms. The technology provides additional clinical insights without requiring extra imaging, radiation, or patient appointments.
Read moreJuly 6, 2026Invision Diagnostics Expands Women's Health Offerings with CureMetrix's cmAngio®
Read moreApril 16, 2026CureMetrix and Cascaid Health Announce Collaboration to Support Coordination Following Radiologist-Reviewed BAC Findings
Read moreFebruary 3, 2026CureMetrix® Brings cmAngio® BAC Detection to Rezolut Imaging Patients
Read moreThe CureMetrix Team
CureMetrix is a team of award-winning, interdisciplinary talent from diverse backgrounds brought together to solve complex challenges in medical imaging and innovate according to market needs. We are computational physicists, data scientists, software developers, consultants, strategists, medical communication experts and market developers. Our team has a track record of publications in peer-reviewed journals with demonstrated expertise in detection and classification of anomalies in extremely noisy, multi-variate data.
Leadership
Medical Advisors
Jade de Guzman, MD
Medical Advisor
Michele McGahan, MD
Medical Advisor
Curtis Duffield, MD
Medical Advisor
Kiran Jain, MD
Medical Advisor
Strategic Advisors
Certifications
CureMetrix maintains the highest standards for quality management and regulatory compliance.
ISO 13485:2016 Quality Management System Certified
CureMetrix is certified to ISO 13485:2016 for the design, development, and manufacture of medical device software.
MDSAP Certification: Medical Device Single Audit Program
CureMetrix is MDSAP certified under registration number 0201679, demonstrating compliance with quality management requirements across multiple regulatory jurisdictions.
Join the Mission
We are building the future of AI-powered healthcare. Interested in partnering or joining our team?